[logo] HealthTree Foundation
more_vert

Delivering Targeted Radiotherapy to Myeloma Cells - CLR 131 with Natalie Callander, MD, University of Wisconsin

Delivering Targeted Radiotherapy to Myeloma Cells - CLR 131 with Natalie Callander, MD, University of Wisconsin image

Delivering Targeted Radiotherapy to Myeloma Cells - CLR 131 with Natalie Callander, MD, University of Wisconsin

Podcast
event Sep 30, 2019 / 11:00AM MDT
link icon facebook logo X logo linkedin logo reddit logo email icon

Event Description

Natalie Callander, MD
University of Wisconsin 
Interview Date: September 30, 2019

Cancer cells have a different thickness of cell membrane than normal cells. A new treatment is exploiting that difference by delivering a targeted therapy to just the cancer cells while avoiding the normal cells. Cellectar is developing a new treatment called CLR 131, which is a compound that allows the delivery of a radioactive iodine to enter specifically into tumor cells. Radioactive iodine has been used for many years to treat thyroid cancer and has a long history of safety and a short half-life. Dr. Callander describes how this is being used in multiple myeloma and other blood cancers to treat relapsed disease. 

Thanks to our episode sponsor

 

Schedule & Agenda

Event panelist Dr. Natalie Callander & Jenny Ahlstrom
11:00 AM
Discussion
Dr. Natalie Callander & Jenny Ahlstrom

Speakers & Moderators

The panelist Natalie Callander, MD
Natalie Callander, MD

Dr. Natalie Callander is a faculty member in Division of Hematology, Medical Oncology and Palliative Care within the Department of Medicine at the University of Wisconsin School of Medicine and Public Health. She is the Director of the UW Carbone Cancer Center Myeloma Clinical and Cellular Therapy Program. She is past Chair of the Bone Marrow Transplant Clinical Trials Network Myeloma Intergroup Committee. She has received three UW Health Patient Experience Physician Champion Awards, named to Best Doctors in America list since 2004, a Madison Magazine Top Doctor three times, and received the Chuck Koval Award for Excellence in Myeloma presented by the Leukemia and Lymphoma Society.

Read Bio
The panelist Jennifer Ahlstrom
Jennifer Ahlstrom

Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can help accelerate a cure by weighing in and participating in clinical research. Founder of the HealthTree Foundation.

Read Bio

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.

support

Get In Touch With Us

phone

1-800-709-1113

email

Support@healthtree.org

newsletter icon

Get the Latest Multiple Myeloma Updates, Delivered to You.

By subscribing to the HealthTree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.

Together we care.

Together we cure.

100% of every dollar you give supports our life-changing mission.